Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9777	Companies
195695	Keywords
126733	Articles
104059	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 10/06/2025 at 15:00, 3 months 24 days ago

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
Napo Pharmaceuticals provides update on ongoing clinical trial for the treatment of MVID in pediatric patients, showing significant reduction in parenteral support in UAE. FDA advice sought for study advancement

FDA Napo Pharmaceuticals Clinical Trial Pediatric Patients MVID
BRIEF

published on 09/30/2025 at 15:05, 4 months ago

Jaguar Health Provides Crofelemer for Pediatric Intestinal Failure Treatment

Crofelemer Microvillus Inclusion Disease Jaguar Health Pediatric Treatment FDA Programs
BRIEF

published on 09/30/2025 at 15:05, 4 months ago

Jaguar Health fournit Crofelemer pour le traitement de l'insuffisance intestinale pédiatrique

Crofelemer Jaguar Health Maladie D'inclusion Microvillositaire Traitement Pédiatrique Programmes De La FDA
PRESS RELEASE

published on 09/30/2025 at 15:00, 4 months ago

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
Jaguar Health announces expanded access programs for pediatric patients with microvillus inclusion disease using crofelemer powder. Positive results from initial trials presented

Microvillus Inclusion Disease Jaguar Health Pediatric Patients Crofelemer Powder Expanded Access Programs
BRIEF

published on 09/26/2025 at 12:22, 4 months 4 days ago

Jaguar Health Inc. réitère sa recommandation d'achat sur ses actions

Financement Jaguar Health Maladies Rares Premier Berlin Recommandation D'actions
BRIEF

published on 09/26/2025 at 12:22, 4 months 4 days ago

Jaguar Health Inc's Stock Recommendation Reiterated as BUY

Funding Jaguar Health Stock Recommendation Rare Diseases First Berlin
PRESS RELEASE

published on 09/26/2025 at 12:17, 4 months 4 days ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates recommendation for Jaguar Health Inc to BUY with a target price of USD 35. Company reports H1/25 results in line with estimates, focuses on securing funding for promising pipeline

Jaguar Health Inc Funding First Berlin Equity Research Buy Recommendation Research Update
BRIEF

published on 09/25/2025 at 15:05, 4 months 5 days ago

Jaguar Health obtient une subvention de 250 000 $ de la FDA pour l'essai Canalevia

Jaguar Health Santé Animale Canalevia Traitement De La Diarrhée Canine Subvention De La FDA
BRIEF

published on 09/25/2025 at 15:05, 4 months 5 days ago

Jaguar Health Secures $250,000 FDA Grant for Canalevia Trial

Jaguar Health Animal Health Canalevia Dog Diarrhea Treatment FDA Grant
PRESS RELEASE

published on 09/25/2025 at 15:00, 4 months 5 days ago

Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Animal Health receives $250,000 grant from FDA's CVM for Canalevia-CA1 to treat chemotherapy-induced diarrhea in dogs. Company seeks to expand partnership for global commercialization of Canalevia

Canalevia-CA1 Chemotherapy-induced Diarrhea Jaguar Animal Health Global Commercialization FDA Grant

Accesswire

Published on 01/31/2026 at 00:00, 2 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 hour 2 minutes ago

Avidian Gold Corp. Announces Director Resignation
Published on 01/30/2026 at 22:45, 1 hour 17 minutes ago

Noram Lithium Announces Fully Allocated Non-Brokered Financing
Published on 01/30/2026 at 22:30, 1 hour 32 minutes ago

Alta Copper Receives Court Approval for Proposed Acquisition by Fortescue
Published on 01/30/2026 at 14:00, 10 hours 2 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 22:00, 2 hours 2 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 3 hours 52 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 3 hours 53 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 3 hours 55 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 19:13, 4 hours 49 minutes ago

Total Voting Rights

Les Echos

Published on 01/30/2026 at 18:40, 5 hours 22 minutes ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 6 hours 1 minute ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 6 hours 17 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 6 hours 17 minutes ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 15 hours 32 minutes ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE